Doramectin; Phenol

Verify with FDA CVM →

233 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
233
Total Reports
97
Deaths Reported
4160.0%
Death Rate

Active Ingredients

Doramectin; Phenol

Administration Routes

SubcutaneousUnknownIntramuscularOralTopicalOther

Species Affected

Cattle 147
Unknown 37
Human 16
Dog 13
Sheep 8
Pig 5
Goat 2
Cat 1
Bison 1
White tailed deer 1

Most Affected Breeds

Cattle (other) 66
Unknown 56
Mixed (Cattle) 52
Aberdeen Angus 16
Sheep (unknown) 5
Holstein-Friesian also known as Holstein 5
Retriever - Labrador 3
Crossbred Bovine/Cattle 2
Crossbred Porcine/Pig 2
Goat (unknown) 2

Most Reported Reactions

Death 64
Lack of efficacy (bacteria) - NOS 44
Lack of efficacy - NOS 42
Uncoded sign 23
Other abnormal test result NOS 16
Abnormal test result 15
Abnormal necropsy finding 12
NT - Abnormal necropsy finding NOS 12
Anaphylactic-type reaction 12
INEFFECTIVE, PARASITE(S) NOS 11
CULTURE/TITER DATA ABNORMAL 11
Precipitate, Sediment 11

Outcome Breakdown

Outcome Unknown
119 (46.1%)
Died
95 (36.8%)
Recovered/Normal
23 (8.9%)
Ongoing
14 (5.4%)
Recovered with Sequela
4 (1.6%)
Euthanized
3 (1.2%)

Data Summary

Metric Value
Total adverse event reports 233
Reports involving death 97
Case-fatality rate (reported events) 4160.0%
Distinct species in reports 10
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Doramectin; Phenol Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 233 adverse event reports referencing Doramectin; Phenol, including 97 reports in which the animal died — a 4160.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Doramectin; Phenol. Reported administration routes include Subcutaneous, Unknown, Intramuscular, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Doramectin; Phenol reports are Cattle (147 reports), Unknown (37 reports), Human (16 reports), with Cattle accounting for the largest share. Within those species, Cattle (other) (66), Unknown (56), Mixed (Cattle) (52) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Doramectin; Phenol are Death (64), Lack of efficacy (bacteria) - NOS (44), Lack of efficacy - NOS (42), Uncoded sign (23). Of the 258 reports with a coded outcome, Outcome Unknown is the leading category at 46.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Doramectin; Phenol.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial